Data as of Aug 29
| +0.015 / +2.46%|
The 2 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 1.75, with a high estimate of 2.50 and a low estimate of 1.00. The median estimate represents a +180.00% increase from the last price of 0.63.
The current consensus among 2 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.